October 2020 Archives by thread
Starting: Thu Oct 1 08:12:35 PDT 2020
Ending: Sat Oct 31 08:59:27 PDT 2020
Messages: 93
- [Ip-health] The Public Access Provisions of the NIH Guidelines on Research Involving Recombinant or Synthetic Nucleic Acid Molecules.
James Love
- [Ip-health] KEI Sues NIH over Improper Witholding of Three FOIA Requests | Knowledge Ecology International
James Love
- [Ip-health] transparency
James Love
- [Ip-health] Global Congress IP&COVID Schedule
Sean Flynn
- [Ip-health] WTO TRIPS Council: India and South Africa submit draft decision text on a waiver from certain provisions of the TRIPS Agreement for the prevention, containment and treatment of COVID-19.
Thiru Balasubramaniam
- [Ip-health] MSF briefing: limitations of voluntary license and recommendations to governments
Yuanqiong HU
- [Ip-health] AP: India, South Africa ask WTO to ease IP rules for COVID-19
Thiru Balasubramaniam
- [Ip-health] Stat: South Africa and India urge WTO to waive IP rights, widen access to Covid-19 drugs and vaccines
Thiru Balasubramaniam
- [Ip-health] Reuters: India and South Africa ask WTO to waive rules to aid COVID-19 drug production
Thiru Balasubramaniam
- [Ip-health] HAI Statement for Special Session of WHO Executive Board on Covid 19 response
Jaume Vidal
- [Ip-health] KEI written statement at the WHO Executive Board special session: Update on implementation of resolution WHA73.1 (2020) on the COVID-19 response
Thiru Balasubramaniam
- [Ip-health] New Medicines Law & Policy paper: How the ‘Oxford’ Covid-19 vaccine became the ‘AstraZeneca’ Covid-19 vaccine
Kaitlin Mara
- [Ip-health] Treatment activist forum
George Carter
- [Ip-health] SouthNews: Action at the WTO is needed to accelerate research, development, manufacturing and supply of medical products to combat Covid-19: Proposal from India and South Africa
Anna Bernardo
- [Ip-health] While the Poor Get Sick, Bill Gates Just Gets Richer
Claire Cassedy
- [Ip-health] Global Congress on IP and COVID Day Schedule
Sean Flynn
- [Ip-health] Webinar Invite- Intellectual Property Rights Regime: Implications for Access to Covid19 Medical Products
K.M. Gopakumar
- [Ip-health] SouthNews: The TRIPS Council on 15-16 October should agree to extend the transition period that exempts Least Developed Countries from implementation of the WTO TRIPS Agreement
Anna Bernardo
- [Ip-health] Position Opening: Campaign Director, Global Vaccine Access @ Public Citizen
Peter Maybarduk
- [Ip-health] Wall Street Journal: Nobel Prize in Chemistry Is Awarded for Crispr Gene-Editing Technology
Thiru Balasubramaniam
- [Ip-health] MSF calls for all governments to support the waiver request made to WTO by South Africa and India
Yuanqiong HU
- [Ip-health] Global Congress Schedule Today
Sean Flynn
- [Ip-health] 10/15 Webinar: The IMF's COVID-19 Response: A Conversation With Joseph E. Stiglitz
GDP Center
- [Ip-health] KEI on Moderna Statement on Intellectual Property Matters during the COVID-19 Pandemic
James Love
- [Ip-health] Geneva Health Files: "Consult us more": Countries to WHO; Action at WTO
Thiru Balasubramaniam
- [Ip-health] KEI on Moderna’s Oct 8, 2020 Statement on Intellectual Property Matters during the COVID-19 Pandemic
Claire Cassedy
- [Ip-health] Wall Street Journal: Moderna Vows to Not Enforce Covid-19 Vaccine Patents During Pandemic
Thiru Balasubramaniam
- [Ip-health] Moderna responds to activist pressure, but int he race for our lives, we need more than baby steps
Baker, Brook
- [Ip-health] Stat: Moderna vows not to enforce Covid-19 patents, but advocates say IP should be given to WHO
Thiru Balasubramaniam
- [Ip-health] Health Policy Watch: Moderna Makes Milestone Pledge To “Not Enforce Our Patents” On COVID-19 Vaccine Technologies During Pandemic & Issue Open Licenses Afterward
Thiru Balasubramaniam
- [Ip-health] Mariana Mazzuato in the New York Times: Capitalism Is Broken. The Fix Begins With a Free Covid-19 Vaccine.
Thiru Balasubramaniam
- [Ip-health] In landmark move, India and South Africa propose no patents on COVID-19 medicines, tools during pandemic
Shailly GUPTA
- [Ip-health] Taxpayers are subsidizing 80 percent of Regeneron’s COVID-19 treatment’s R&D costs
kathryn ardizzone
- [Ip-health] The Economist: Who won this year’s Nobel science prizes? The laureates proved black holes are real, created a new form of gene editing and identified the hepatitis C virus
Thiru Balasubramaniam
- [Ip-health] Legal authority for Trump's $200 drug cards, from the Medicare Trust Fund
James Love
- [Ip-health] NIH responds (sort of) to questions about Petragen, Inc., a start-up company incorporated in the state of Delaware
James Love
- [Ip-health] Prospective Grant of an Exclusive Patent Commercialization License: Method of Treating Periodontal Disease via ENPP1 Inhibition to Petragen, a company with no web page or SEC filings.
James Love
- [Ip-health] Health Policy Watch: China, Republic of Korea Join COVAX Global Vaccine Pool – WHO Urges Countries To Jumpstart Vaccine Campaigns
Thiru Balasubramaniam
- [Ip-health] Invitation to Attend the Talk is the Best Medicine Podcast on 10/13
Global Health Impact Project
- [Ip-health] South Africa and India’s Proposal to Waive Recognition and Enforcement of Intellectual Property Rights for COVID-19 Medical Technologies Deserves Universal Support, But Countries Also Have to Take Domestic Measures
Baker, Brook
- [Ip-health] KEI panel on government funding of COVID drugs and vaccines at the Global Congress on Intellectual Property and the Public Interest
Luis Gil Abinader
- [Ip-health] South African Academics Letter to President Ramaphosa to Take Decisive Action on the Proposed WTO Waiver on COVID-19
Yousuf Abdoola Vawda
- [Ip-health] Ellen 't Hoen in The Wire - COVID-19 Crisis and WTO: Why India and South Africa’s Proposal on Intellectual Property is Important
Kaitlin Mara
- [Ip-health] DNDi's Dr. Bernard Pecoul on South Africa/India TRIPS proposal
Rachel M. Cohen
- [Ip-health] Unitaid supports call for intellectual property waivers and action for access to COVID-19 products
HARVEY ALLCHURCH, Martin
- [Ip-health] Oct 22 Webinar on COVID-19 and Bioethics
Chieko Kurihara
- [Ip-health] 20 October 2020 – Save the Date – Government Funding of COVID-19 Vaccines and Other Medical Technologies
Thiru Balasubramaniam
- [Ip-health] KEI Obtains AztraZeneca COVID-19 and Moderna Vaccine Contracts via FOIA Request
Claire Cassedy
- [Ip-health] Webinar: Building access into pharmaceutical R&D agreements: ideas and possibilities from real-world contracts, Oct 28
Marcela Vieira
- [Ip-health] Health Policy Watch: World Trade Organization Enters COVID Pandemic Fray With Dispute Brewing Over Patent Rights
Thiru Balasubramaniam
- [Ip-health] Stat: Hundreds of advocacy groups urge WTO to waive IP rights to Covid-19 drugs and vaccines
Thiru Balasubramaniam
- [Ip-health] CSO Letter Support India & South Africa Waiver Proposal
Sangeeta Shashikant
- [Ip-health] Links to CSO Letter Supporting India & South Africa Waiver Proposal
Sangeeta Shashikant
- [Ip-health] EU position WTO TRIPS
Ella Weggen
- [Ip-health] NEW South Centre Research Paper: TRIPS Flexibilities on Patent Enforcement: Lessons from Some Developed Countries Relating to Pharmaceutical Patent Protection
Anna Bernardo
- [Ip-health] UNAIDS press statement: UNAIDS supports a temporary WTO waiver from certain obligations of the TRIPS Agreement in relation to the prevention, containment and treatment of COVID-19
Thiru Balasubramaniam
- [Ip-health] Public Citizen Sues USG, Demands Release of Billion Dollar Vaccine Contracts
Zain Rizvi
- [Ip-health] FIX THE PATENT LAWS COALITION SUPPORTS SOUTH AFRICA AND INDIA’S PROPOSAL TO FACILITATE ACCESS TO COVID-19 VACCINES
Thiru Balasubramaniam
- [Ip-health] KEI (October 9) FOIA lawsuit over NIH documents related to COVID 19 contracts and collaborations | Knowledge Ecology International
James Love
- [Ip-health] MSF statement supporting the extension of TRIPS exemption for least-developed countries
Yuanqiong HU
- [Ip-health] Brazil opposes emerging markets and denies support for vaccine patent suspension
Luis Gil Abinader
- [Ip-health] KEI Sues HHS and the Army over access to COVID-19 Contracts
kathryn ardizzone
- [Ip-health] Fwd: Clinical Pharmacology Corner: FDA Approves INMAZEB (Atoltivimab, Maftivimab, and Odesivimab)
George Carter
- [Ip-health] WTO TRIPS Council (October 2020): South Africa issues clarion call urging support for TRIPS waiver proposal
Thiru Balasubramaniam
- [Ip-health] Inflection Point? TRIPS Waiver proposal
Priti Patnaik
- [Ip-health] Reminder - 20 October 2020 - Government Funding of COVID-19 Vaccines and Other Medical Technologies
Thiru Balasubramaniam
- [Ip-health] No consensus on India-South Africa's WTO proposal to waive off patent rights for COVID-19 innovation
K.M. Gopakumar
- [Ip-health] WHO lends support to IP-waiver proposal from South Africa, India
K.M. Gopakumar
- [Ip-health] SouthViews: Access to medical supplies and devices — the lesser known story of COVID-19 and medical monopoly
Anna Bernardo
- [Ip-health] Fwd: TWN Info: Proposal for TRIPS waiver secures strong support from South
Chee Yoke Ling
- [Ip-health] Fwd: TWN Info: South Africa, India strongly rebut arguments against TRIPS waiver
Chee Yoke Ling
- [Ip-health] WTO TRIPS Council (October 2020): Hungary answers queries posed by South Africa regarding Hungarian compulsory licensing provisions
Thiru Balasubramaniam
- [Ip-health] WTO TRIPS Council (October 2020): European Union dismisses concerns that IPRs are a barrier to COVID-19 medicines and technologies
Thiru Balasubramaniam
- [Ip-health] Regeneron failed to disclose BARDA funding in their REGN-COV2 patent
Luis Gil Abinader
- [Ip-health] Health Impact Fund webinar
Aidan Hollis
- [Ip-health] NEW South Centre Research Paper: Patent Analysis for Medicines and Biotherapeutics in Trials to Treat COVID-19
Anna Bernardo
- [Ip-health] Wall Street Journal: Oxford Developed Covid Vaccine, Then Scholars Clashed Over Money
Thiru Balasubramaniam
- [Ip-health] U.S. Government funding of Lilly’s LY-CoV555 antibody against COVID-19
Luis Gil Abinader
- [Ip-health] WEBINAR Nov. 15: Presentation of the TRIPS+ Preferential Trade Agreement Dataset by Jean-Frédéric Morin
Michael Palmedo
- [Ip-health] Health Policy Watch: Gavi Board Chair Okonjo-Iweala Is Recommended As Next World Trade Organization Director-General – US Opposition Stalls Final WTO Decision
Thiru Balasubramaniam
- [Ip-health] Human Rights Watch: Rights, Transparency Central for Covid-19 Vaccines
Thiru Balasubramaniam
- [Ip-health] Petition SA govt to demand equitable access to COVID-19 medicines
Baker, Brook
- [Ip-health] SouthViews: Creative imitation at the front of pharma biotechnology opportunities: some lessons from late late industrialization countries
Anna Bernardo
- [Ip-health] Corporate Charity – Is The Gates Foundation Addressing Or Reinforcing Systemic Problems Raised By COVID-19?
Rohit Malpani
Last message date:
Sat Oct 31 08:59:27 PDT 2020
Archived on: Sat Oct 31 09:15:32 PDT 2020
This archive was generated by
Pipermail 0.09 (Mailman edition).